Altium Capital Management LLC / ABOS
Altium Capital Management LLC’s Acumen Pharmaceuticals Inc Position
Does Altium Capital Management LLC own Acumen Pharmaceuticals Inc (ABOS)? Not currently — the last reported position was 650.0K shares worth $3M in Q3 2023; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$3M
Q3 2023
Shares
650.0K
% of Portfolio
+1.41%
Quarters Held
1
position exited
Position History ABOS
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2023 | 650.0K | $3M | +1.41% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Altium Capital Management LLC’s full portfolio or all institutional holders of ABOS.